This table presents recent patent oppositions filed by Moderna Therapeutics, Inc. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3115064Rna-Coded AntibodyCUREVAC AGAug 24, 2022

The following table provides an overview of the latest patents of Moderna Therapeutics, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions10
EP2922554Feb 23, 2022Terminally Modified Rna1
EP3019619Aug 25, 2021Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use2
EP3492109Mar 4, 2020Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof2